Lung Cancer Diagnostics Market to Witness Healthy CAGR of 14.2% by 2030, Size, Share, Trends, Opportunities, Key Growth Drivers and Future Outlook
03 janv. 2023 15h30 HE
|
Data Bridge Market Research
NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Lung Cancer Diagnostics Market" with 100+ market data tables, pie charts, graphs, and...
Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Circulating Biomarkers, By Application, By Region And Segment Forecasts, 2022 - 2030
15 déc. 2022 11h59 HE
|
ReportLinker
New York, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Circulating...
Insights on the Liquid Biopsy Global Market to 2027 - Extracellular Vesicles Show Promise as Early-Stage Cancer Diagnostic
25 nov. 2022 06h08 HE
|
Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and...
Liquid Biopsy Market Research Report by Product, Sample, Type, Technology, End User, Application, Indication, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
10 nov. 2022 06h52 HE
|
ReportLinker
New York, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Liquid Biopsy Market Research Report by Product, Sample, Type, Technology, End User, Application,...
Minimal Residual Disease Market Size to Reach USD 3927.60 Million by 2030, Says The Brainy Insights
27 oct. 2022 07h46 HE
|
The Brainy Insights
Newark, Oct. 27, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global minimal residual disease market is expected to grow from USD 1259.20 million in 2022 to USD...
Global Clinical Biomarkers Market Research Report 2022: Rising Key Player Initiatives & Increasing Demand for Clinical Biomarker Products
08 sept. 2022 06h28 HE
|
Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "Clinical Biomarkers - A Global and Regional Analysis: Focus on Offering, Clinical Area, Technology, Application, End User, and Region - Analysis and...
Inivata and Collaborators to Present New Data to Support the Application of RaDaR™ MRD Assay Across Tumor Types at ESMO Congress 2022
07 sept. 2022 02h44 HE
|
Inivata
Inivata and Collaborators to Present New Data to Support the Application of RaDaR™ MRD Assay Across Tumor Types at ESMO Congress 2022 Research Triangle Park, NC, USA and Cambridge, UK, 7 September...
Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors
31 août 2022 09h00 HE
|
Nanomix Corporation
SAN LEANDRO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics,...
global clinical biomarkers market during the forecast period 2022-2032
19 août 2022 07h50 HE
|
ReportLinker
New York, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Biomarkers - A Global and Regional Analysis: Focus on Offering, Clinical Area, Technology,...
Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger as Chief Executive Officer and Member of the Board of Directors
26 juil. 2022 09h30 HE
|
Nanomix Corporation
SAN LEANDRO, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced the...